Your session is about to expire
← Back to Search
Digital Therapeutics
Digital Therapy Apps for Childhood Behavior Problems
N/A
Recruiting
Led By Oliver Lindhiem, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-month follow-up (10 months after baseline).
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a smartphone app called UseIt! to help parents manage their children's disruptive behaviors. The app can be used alone or with help from a coach. It teaches parents effective behavior management techniques.
Who is the study for?
This trial is for children aged 5-8 who often show disruptive behaviors and live with a parent most of the time. The child must score high on a behavior scale, and their parent needs to have a smartphone with daily internet. Kids already in treatment or with certain mental health conditions can't join.
What is being tested?
The study tests an mHealth system's effectiveness for managing childhood behavior problems using two apps: UseIt! App alone, UseIt! App with coach assistance, versus SmilingMind (control). Parents are randomly placed into one of these three groups.
What are the potential side effects?
Since this trial involves digital apps and coaching rather than medication, traditional physical side effects aren't expected. However, there may be indirect effects like increased screen time or potential frustration if the app doesn't improve behaviors.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6-month follow-up (10 months after baseline).
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-month follow-up (10 months after baseline).
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Knowledge of Effective Parenting Test (KEPT)
Secondary study objectives
Conduct Disorder Subscale of the Vanderbilt Assessment
Oppositional Defiant Disorder Subscale of the Vanderbilt Assessment
Parenting Skill Use Diary (PSUD)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Group 2: App plus CoachExperimental Treatment2 Interventions
Standalone parenting app called UseIt! plus a coach.
Group II: Group 1: Standalone AppExperimental Treatment1 Intervention
Standalone parenting app called UseIt!
Group III: Group 3: Control AppActive Control1 Intervention
Control condition: mindfulness app called SmilingMind.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for disruptive behaviors include cognitive-behavioral interventions and digital health technologies such as mobile health (mHealth) systems. These treatments work by providing structured behavioral strategies and real-time feedback to help patients manage their behaviors.
Cognitive-behavioral interventions focus on changing negative thought patterns and behaviors through techniques like cognitive rehearsal and skills training. Digital health technologies enhance these interventions by offering accessible, scalable, and instant support through mobile apps, which can include features like goal setting, progress tracking, and personalized feedback.
These mechanisms are crucial for patients with disruptive behaviors as they provide continuous support and reinforcement, making it easier to implement and maintain positive behavior changes in daily life.
Understanding Implementation of a Digital Self-Monitoring Intervention for Relapse Prevention in Psychosis: Protocol for a Mixed Method Process Evaluation.Behavior Change Content, Understandability, and Actionability of Chronic Condition Self-Management Apps Available in France: Systematic Search and Evaluation.Responding to disruptive behaviors in nursing: A longitudinal, quasi-experimental investigation of training for nursing students.
Understanding Implementation of a Digital Self-Monitoring Intervention for Relapse Prevention in Psychosis: Protocol for a Mixed Method Process Evaluation.Behavior Change Content, Understandability, and Actionability of Chronic Condition Self-Management Apps Available in France: Systematic Search and Evaluation.Responding to disruptive behaviors in nursing: A longitudinal, quasi-experimental investigation of training for nursing students.
Find a Location
Who is running the clinical trial?
University of PittsburghLead Sponsor
1,791 Previous Clinical Trials
16,359,472 Total Patients Enrolled
5 Trials studying Problem Behavior
25,581 Patients Enrolled for Problem Behavior
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,067 Previous Clinical Trials
2,747,399 Total Patients Enrolled
7 Trials studying Problem Behavior
4,085 Patients Enrolled for Problem Behavior
Oliver Lindhiem, PhDPrincipal InvestigatorUniversity of Pittsburgh, Department of Psychiatry
2 Previous Clinical Trials
153 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 5 and 8 years old.I have a diagnosed mental health condition like bipolar disorder or major depression.
Research Study Groups:
This trial has the following groups:- Group 1: Group 1: Standalone App
- Group 2: Group 2: App plus Coach
- Group 3: Group 3: Control App
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.